These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 21315276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection.
    Luo TY, Hsieh BT, Wang SJ, Lin WY, Lee TW, Shen LH, Su MJ.
    Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 188Re-HDD/lipiodol for treatment of hepatocellular carcinoma: a feasibility study in patients with advanced cirrhosis.
    Lambert B, Bacher K, De Keukeleire K, Smeets P, Colle I, Jeong JM, Thierens H, Troisi R, De Vos F, Van de Wiele C.
    J Nucl Med; 2005 Aug; 46(8):1326-32. PubMed ID: 16085590
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
    Tang IC, Luo TY, Liu SW, Chan SH, Kung HC, Peng CL, Lin WY, Chang Y, Lin WJ.
    Nucl Med Biol; 2011 Oct; 38(7):1043-52. PubMed ID: 21831647
    [Abstract] [Full Text] [Related]

  • 11. Lipiodol solution of a lipophilic agent, (188)Re-TDD, for the treatment of liver cancer.
    Jeong JM, Kim YJ, Lee YS, Ko JI, Son M, Lee DS, Chung JK, Park JH, Lee MC.
    Nucl Med Biol; 2001 Feb; 28(2):197-204. PubMed ID: 11295430
    [Abstract] [Full Text] [Related]

  • 12. Effect of a 188 Re-SSS lipiodol/131I-lipiodol mixture, 188 Re-SSS lipiodol alone or 131I-lipiodol alone on the survival of rats with hepatocellular carcinoma.
    Garin E, Rakotonirina H, Lejeune F, Denizot B, Roux J, Noiret N, Mesbah H, Herry JY, Bourguet P, Lejeune JJ.
    Nucl Med Commun; 2006 Apr; 27(4):363-9. PubMed ID: 16531923
    [Abstract] [Full Text] [Related]

  • 13. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer.
    Das T, Chakraborty S, Sarma HD, Venkatesh M, Banerjee S.
    Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A report on the implementation aspects of the International Atomic Energy Agency's first doctoral coordinated research project, "Management of liver cancer using radionuclide methods with special emphasis on trans-arterial radio-conjugate therapy and internal dosimetry".
    Padhy AK, Dondi M.
    Semin Nucl Med; 2008 Mar; 38(2):S5-12. PubMed ID: 18243843
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma.
    Huang PW, Tsai SC, Luo TY, Kao CH, Lin WY.
    Ann Nucl Med; 2013 Jul; 27(6):532-7. PubMed ID: 23479326
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment.
    Lepareur N, Laffont S, Ardisson V, Noiret N, Garin E.
    Nucl Med Commun; 2012 Feb; 33(2):205-8. PubMed ID: 22124362
    [Abstract] [Full Text] [Related]

  • 19. Evaluating the potential of (188)Re-ECD/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatment.
    Luo TY, Shih YH, Chen CY, Tang IC, Wu YL, Kung HC, Lin WJ, Lin XZ.
    Cancer Biother Radiopharm; 2009 Oct; 24(5):535-41. PubMed ID: 19877883
    [Abstract] [Full Text] [Related]

  • 20. Advantage of 188Re-radiopharmaceuticals in hepatocellular cancer and liver metastases.
    Liepe K, Kotzerke J, Lambert B.
    J Nucl Med; 2005 Aug; 46(8):1407-8; author reply 1407-8. PubMed ID: 16085601
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.